Aerosol drug delivery devices market to triple in size by 2032, driven by respiratory disorders
From GlobeNewswire: 2025-02-28 09:00:00
The Aerosol Drug Delivery Devices Market was valued at USD 26.40 billion in 2023, set to reach USD 80.43 billion by 2032 with a CAGR of 13.19%. Increasing respiratory disorders drive growth. Key players include AptarGroup, Koninklijke Philips, AstraZeneca, and Novartis. Inhalers dominated in 2023, with COPD leading applications and North America dominating the market.
Technology improvements in aerosol drug delivery devices, such as smart inhalers and green propellants, are driving market growth. Inhalers accounted for 86.3% of revenue in 2023, with smart inhalers showing rapid growth. COPD applications led the market, with institutional pharmacies dominating distribution. Online pharmacies are expected to grow rapidly post-pandemic.
North America led the aerosol drug delivery devices market in 2023, with Asia-Pacific expected to grow the fastest due to rising healthcare expenditure. Recent developments include Aerogen investing in Ireland and Aero Pump collaborating with Resyca. Global incidence of COPD and asthma is on the rise, with smart inhaler adoption increasing by 25% worldwide. The Aerosol Drug Delivery Devices Market Analysis & Outlook for 2024-2032 includes insights on device adoption rates, regulatory approvals, healthcare expenditure trends, and more. The report also covers the competitive landscape, market segmentation by type, application, and distribution, regional analysis, company profiles, and best practices. Access the complete report details at https://www.snsinsider.com/reports/aerosol-drug-delivery-devices-market-5618.
SNS Insider is a top market research and consulting agency providing global market insights to help clients navigate changing circumstances. Utilizing surveys, video talks, and focus groups, we deliver accurate market data and consumer insights for confident decision-making.
Read more at GlobeNewswire: Aerosol Drug Delivery Devices Market to Hit USD 80 Billion
